Roche Holding AG Other Non-Current Liabilities 2010-2024 | RHHBY

  • Roche Holding AG other non-current liabilities for 2023 were $7.774B, a 8.13% increase from 2022.
  • Roche Holding AG other non-current liabilities for 2022 were $7.19B, a 25.76% decline from 2021.
  • Roche Holding AG other non-current liabilities for 2021 were $9.685B, a 12.61% decline from 2020.

Quarterly Chart

Click on chart icon to view chart
Click on table icon to view table

Quarterly - YOY Change

Click on chart icon to view chart
Click on table icon to view table

Annual

Click on chart icon to view chart
Click on table icon to view table

Annual % Change

Click on chart icon to view chart
Click on table icon to view table
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B